Kawasaki disease, Epstein-Barr virus and coronary artery aneurysms

Journal of Clinical Pathology

Volumn 50, Issue 2, 1997, Pages 161-163

  Culora, G A ^a   Moore, I E ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Epstein Barr virus; Kawasaki disease

Indexed keywords

ARTICLE; AUTOPSY; CASE REPORT; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0031056324     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.2.161     Document Type: Article

References (20)

1. Levin M, Tizard EJ, Dillon MJ. Kawasaki disease: recent advances. Arch Dis Child 1991;66:1369-74.
2. Koren G, Lavi S, Rose V, Rowe R, Kawasaki disease, a review of risk factors for coronary aneurysms. J Pediatr 1986;108:388-9.
3. Rowley AH, Gonzales-Crussi F, Shulman ST, Kawasaki syndrome. Rev Infect Dis 1988;10:1-15.
4. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057-61.
5. Hsu CH, Chen MR, Hwang FY, Kao HA, Hung HY, Hsu CH. Efficacy of plasmin-treated intravenous gammaglobulin for therapy of Kawasaki syndrome. Pediatr Infect Dis J 1993;12:509-12.
6. Wreford FS, Conradi SE, Cohle SD, Lie JT, Dana SE, Puri S. Sudden death caused by coronary artery aneurysms: a late complication of Kawasaki disease. J Forensic Sci 1990; 36:51-9.
7. Hamashima Y, Kishi K, Tasaka K. Rickettsia-like bodies in infantile acute febrile mucocutaneous lymph node syndrome [letter]. Lancet 1973;ii:42.
8. Kegel SM, Dorsey TJ, Rowen M, Taylor WF. Cardiac death in mucocutaneous lymph node syndrome. Am J Cardiol 1977;40:282-6.
9. Yanagihara R, Todd JK. Acute febrile mucocutaneous lymph node syndrome. Am J Dis Child 1980;138:603-15.
10. Shulman ST, Rowley AH. Does Kawasaki disease have a retroviral aetiology? Lancet 1986;ii:545-6.
11. Leung DYM, Chu ET, Wood N, Grady S, Meade R, Geha RS. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 1983;130:2002-4.
12. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-8.
13. Leung DYM, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 1995;155: 5018-21.
14. Kikuta H, Mizuno F, Osato T. Kawasaki disease and an unusual primary infection with Epstein-Barr virus [letter]. Pediatrics 1984;73:413-14
15. Kikuta H, Matsumoto S, Yanase Y, Kawasaki T, Mizuno F, Osato T. Recurrence of Kawasaki disease and Epstein-Barr virus infection [letter]. J Infect Dis 1990;162:1215.
16. Kikuta H, Nakanishi M, Ishikawa N, Konno M, Matsumoto S. Detection of Epstein-Barr virus sequences in patients with Kawasaki disease by means of the polymerase chain reaction. Intervirology 1992;33:1-5.
17. Kikuta H, Sakiyama Y, Matsumoto S, Hamada I, Yazaki M, Iwaki T, et al. Detection of Epstein-Barr virus DKA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms. J Pediatr 1993;123:90-2.
18. Purtilo DT, Luka J, Patton H, Fujiwara H, Fujiwara T, England J, et al. EBV genome detection in tissues of patients with Kawasaki syndrome [abstract]. Lab Invest 1993;68: 106A.
19. Melish ME, Hicks RM. Mucocutaneous lymph node-syndrome in the United States. Am J Dis Child 1976;130: 599-607.
20. Akagi T, Rose V, Benson LN, Newman A, Freedom RM. Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 1992;121:689-94.